Drug
futibatinib
Marketed as LYTGOBI.
Generic name
futibatinib
Brand names
LYTGOBI
First FDA approval
2022-09-30
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA214801 | LYTGOBI | 2022-09-30 | TAIHO ONCOLOGY |
Manufacturers
TAIHO ONCOLOGY
Frequently asked questions
When was futibatinib FDA approved?
Earliest FDA approval on record: 2022-09-30.
What brand names are sold as futibatinib?
LYTGOBI.
Sources
Appeal a futibatinib denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com